|
NCK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.3012002586521E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18659526648912E-11 |
| Normal-vs-Stage2 |
7.679700E-03 |
| Normal-vs-Stage3 |
8.165800000004E-05 |
| Normal-vs-Stage4 |
1.151530E-02 |
| Stage1-vs-Stage2 |
4.687200E-01 |
| Stage1-vs-Stage3 |
2.622800E-01 |
| Stage1-vs-Stage4 |
4.936000E-03 |
| Stage2-vs-Stage3 |
9.898200E-01 |
| Stage2-vs-Stage4 |
3.226400E-01 |
| Stage3-vs-Stage4 |
1.803030E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06709974190267E-10 |
| Normal-vs-AfricanAmerican |
1.147650E-02 |
| Normal-vs-Asian |
1.81339999999475E-05 |
| Caucasian-vs-AfricanAmerican |
8.945200E-01 |
| Caucasian-vs-Asian |
9.823200E-01 |
| AfricanAmerican-vs-Asian |
8.890800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7284999955296E-08 |
| Normal-vs-Female |
1.16789999893285E-09 |
| Male-vs-Female |
5.357200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.24139637142684E-11 |
| Normal-vs-Age(41-60Yrs) |
7.21600001973854E-09 |
| Normal-vs-Age(61-80Yrs) |
1.304380E-02 |
| Normal-vs-Age(81-100Yrs) |
7.024600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.343400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.479150E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.379900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.510120E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.227190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.866000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.640200E-02 |
| Classical-VS-Follicular |
6.842700E-03 |
| Classical-VS-Other |
9.584400E-01 |
| Classical-VS-Normal |
1.62014845983549E-12 |
| Tall-VS-Follicular |
9.217800E-01 |
| Tall-VS-Other |
4.618200E-01 |
| Tall-VS-Normal |
4.804200E-02 |
| Follicular-VS-Other |
4.101400E-01 |
| Follicular-VS-Normal |
5.861600E-03 |
| Other-VS-Normal |
1.281830E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.67380000029682E-07 |
| Normal-vs-N1 |
1.083470E-03 |
| N0-vs-N1 |
9.938800E-01 |
|
|
